Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
terminated250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates

NCT05494216
completednot_applicable

Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI

NCT03398317
terminatednot_applicable

Application of MACS and Time-lapse Technology in Good-prognosis Patients

NCT01908569
terminatednot_applicable

Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?

NCT02214537

Clinical Trials (4)

Showing 4 of 4 trials
NCT05494216Not Applicable

Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates

Completed
NCT03398317Not Applicable

Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI

Completed
NCT01908569Not Applicable

Application of MACS and Time-lapse Technology in Good-prognosis Patients

Terminated
NCT02214537Not Applicable

Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?

Terminated

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4